Disease | cystic fibrosis |
Symptom | C0035243|respiratory infection |
Sentences | 9 |
PubMedID- 24461904 | respiratory infections in patients with cystic fibrosis undergoing lung transplantation. |
PubMedID- 19918014 | Potential risk factors for death measured at baseline included age, sex, ethnicity, bmi, pulmonary function, diabetes, respiratory infections, class of cystic fibrosis transmembrane conductance regulator (cftr) alleles, diagnosis of cystic fibrosis by neonatal screening, prior organ transplantation, and other medical interventions as described below. |
PubMedID- 26038837 | Scedosporium boydii is a pathogenic filamentous fungus that causes a wide range of human infections, notably respiratory infections in patients with cystic fibrosis. |
PubMedID- 20817772 | Pseudomonas aeruginosa is an opportunistic pathogen that causes acute, invasive infections in immunocompromised individuals and chronic, persistent respiratory infections in individuals with cystic fibrosis (cf). |
PubMedID- 22848580 | Burkholderia cenocepacia is an opportunistic pathogen that survives intracellularly in macrophages and causes serious respiratory infections in patients with cystic fibrosis. |
PubMedID- 24614163 | P. aeruginosa is the predominate pathogen in chronic respiratory infections in patients with cystic fibrosis. |
PubMedID- 25815200 | 2010 dabigatranprevention of stroke or systemic embolism in patients with non-valvular atrial fibrillationboehringer ingelheim pty ltdpbsfinancially-basedpublic summary document atomoxetine hydrochlorideadhd diagnosed between the ages of 6 and 18 yearseli lilly australia pty ltdpbsfinancially-basedpublic summary document fingolimodrrmsnovartis pharmaceuticals australia pty ltdpbsfinancially-based; outcome-basedpublic summary document cinacalcet hydrochlorideend stage renal disease receiving dialysis who have uncontrolled secondary hyperparathyroidismamgen australia pty ltdpbsfinancially-basedpbs schedule , public summary document clostridium botulinum type a toxin-haemagglutinin complexsevere spasticity of the upper limb in adults following a stroke, as an adjunct to physical therapyipsen pty ltdpbsfinancially-basedpublic summary document fentanyl citratefentanyl lozenges for the treatment of breakthrough painorphan australia pty ltdpbsfinancially-basedpublic summary document natalizumabrrmsbiogen idec australia pty ltdpbsfinancially-basedpublic summary document paliperidoneschizophreniajanssen-cilag pty ltdpbsfinancially-basedpublic summary document botulinum toxin type a purified neurotoxin complexmoderate to severe spasticity of the upper limb in adults following a stroke as an adjunct to physical therapyallergan australia pty ltdpbsfinancially-basedpublic summary document tenofovir disoproxil fumaratetreatment of chronic hepatitis bgilead sciences pty ltdpbsfinancially-basedpublic summary document pramipexole hydrochlorideidiopathic parkinson diseaseboehringer ingelheim pty ltdpbsfinancially-basedpublic summary document tobramycinpseudomonas aeruginosa respiratory infection in a patient with cystic fibrosisnovartis pharmaceuticals australia pty ltdpbsfinancially-basedpublic summary document ticagreloracs, mi, or unstable anginaastrazeneca pty ltdpbsfinancially-basedpublic summary document pregabalinneuropathic painpfizer australia pty ltdpbsfinancially-basedpublic summary document rivaroxabanacute symptomatic dvtbayer australia ltdpbsfinancially-basedpublic summary document aztreonampseudomonas aeruginosa infection in patients with cystic fibrosisgilead sciences pty ltdpbsfinancially-basedpublic summary document crinone (progesterone gel)supplement progesterone in women who have luteal phase defectmerck seronopbsfinancially-basedrobertson et al. |
PubMedID- 24300299 | Mp-376 was developed for the management of cystic fibrosis (cf) patients with chronic respiratory infections due to pseudomonas aeruginosa . |
PubMedID- 25480685 | The bacterium pseudomonas aeruginosa is a significant cause of acute nosocomial infections as well as chronic respiratory infections in patients with cystic fibrosis (cf). |
Page: 1